Marjolein de Bruin‐Weller

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Andrew Blauvelt, Marjolein de Bruin‐Weller, Melinda Gooderham et al. · The Lancet · 2017 · 1.2K citations · Full text

Allergy, Atopic Dermatitis, Allergy Medicine +8

Epidemiology of atopic dermatitis in adults: Results from an international survey

S. Barbarot, S. Auziere, A. Gadkari et al. · Allergy · 2018 · 849 citations · Full text

Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t

Marjolein de Bruin‐Weller, Diamant Thaçi, Catherine Smith et al. · British Journal of Dermatology · 2017 · 468 citations · Full text

Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis

Andrew Blauvelt, Henrique D. Teixeira, Eric L. Simpson et al. · JAMA Dermatology · 2021 · 451 citations · Full text

ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children

Andreas Wollenberg, Stéphanie Christen-Zäch, C. Paul et al. · Journal of the European Academy of Dermatology and Venereology · 2020 · 445 citations · Full text

Asthma, Allergy Medicine, Immunology +17